TipRanks
Go Ultimate55% OFF

Eocene (EOCN) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
AramcholHealthyPhase INot Yet RecruitingSingle and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine TabletNov 14, 2025―
Aramchol Meglumine, Aramchol Free AcidHealthyPhase IActive Not RecruitingComparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid TabletsJul 09, 2024―
Aramchol MegluminePrimary Sclerosing CholangitisPhase IIWithdrawnA Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing CholangitisOct 11, 2023―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Eocene Ltd. (EOCN) have in its pipeline
Eocene EOCN is currently developing the following drugs: Aramchol, Aramchol Meglumine, Aramchol Free Acid, Aramchol Meglumine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.